(E)-ethyl-3-(2, 4, 5-trifluorophenyl)acetate | 882856-63-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (E)-ethyl-3-(2, 4, 5-trifluorophenyl)acetate
• 英文别名: ethyl 3-(2,4,5-trifluorophenyl)acrylate；(E)-ethyl3-(2,4,5-trifluorophenyl)acrylate；ethyl (E)-3-(2,4,5-trifluorophenyl)prop-2-enoate
• CAS: 882856-63-5
• 化学式: C₁₁H₉F₃O₂
• 分子量: 230.186
• InChiKey: AODMFHNJISFCRH-ONEGZZNKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (E)-ethyl-3-(2, 4, 5-trifluorophenyl)acetate 在 (2R)-2-[二苯基[(三甲基硅酯)氧基]甲基]-吡咯烷 、 三氧化硫吡啶 、 二异丁基氢化铝 、 三乙胺 作用下， 以 甲醇 、 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 68.5h， 生成 (R)-4-nitro-3-(2,4,5-trifluorophenyl)butanal
  参考文献：
  名称：

  通过二苯基脯氨醇甲硅烷基醚介导的四组分偶联一锅高产DPP4选择性抑制剂ABT-341

  摘要：

  梦想成真：在由二苯基脯氨醇甲硅烷基醚介导的一锅法中，高收率合成ABT-341，具有出色的非对映异构和对映选择性（参见方案； TMS =三甲基甲硅烷基）。因此，一个不对称的迈克尔反应，一个多米诺骨牌迈克尔/霍纳-沃兹沃思-埃蒙斯反应与一个逆醛醇反应，碱催化的异构化反应，酰胺键的形成以及硝基的还原都在一个烧瓶中进行。

  DOI：

  10.1002/anie.201006204
• 作为产物：
  描述：

  乙氧甲酰基亚甲基三苯基膦 、 2,4,5-三氟苯甲醛 以 苯 为溶剂， 反应 16.0h， 以100%的产率得到(E)-ethyl-3-(2, 4, 5-trifluorophenyl)acetate
  参考文献：
  名称：

  通过二苯基脯氨醇甲硅烷基醚介导的四组分偶联一锅高产DPP4选择性抑制剂ABT-341

  摘要：

  梦想成真：在由二苯基脯氨醇甲硅烷基醚介导的一锅法中，高收率合成ABT-341，具有出色的非对映异构和对映选择性（参见方案； TMS =三甲基甲硅烷基）。因此，一个不对称的迈克尔反应，一个多米诺骨牌迈克尔/霍纳-沃兹沃思-埃蒙斯反应与一个逆醛醇反应，碱催化的异构化反应，酰胺键的形成以及硝基的还原都在一个烧瓶中进行。

  DOI：

  10.1002/anie.201006204

文献信息

• Fused Aminopiperidines as Dipeptidyl Peptidase-4 Inhibitors for the Treatment or Prevention of Diabetes
  申请人：Cox Jason M.

  公开号：US20090233936A1

  公开（公告）日：2009-09-17

  The present invention is directed to novel substituted fused aminopiperidines of structural formula (I) which are inhibitors of the dipeptidyl peptidase-4 enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-4 enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-4 enzyme is involved.

  本发明涉及一种新颖的结构式（I）的取代融合氨基哌啶，其是二肽基肽酶-4酶的抑制剂，并且在治疗或预防二肽基肽酶-4酶参与的疾病中，例如糖尿病和特别是2型糖尿病中有用。本发明还涉及包含这些化合物的制药组合物以及这些化合物和组合物在预防或治疗二肽基肽酶-4酶参与的这些疾病中的使用。
• Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
  申请人：Cox M. Jason

  公开号：US20080076773A1

  公开（公告）日：2008-03-27

  The present invention is directed to novel substituted aminopiperidines which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

  本发明涉及一种新型的取代氨基哌啶，它是二肽基肽酶-IV酶（“DPP-IV酶”）的抑制剂，并且在治疗或预防DPP-IV酶参与的疾病，如糖尿病，尤其是2型糖尿病方面具有用处。本发明还涉及包含这些化合物的制药组合物，以及使用这些化合物和组合物在预防或治疗DPP-IV酶参与的这些疾病方面的用途。
• Fused Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
  申请人：Cox Jason M.

  公开号：US20090258894A1

  公开（公告）日：2009-10-15

  The present invention is directed to novel substituted fused aminopiperidines which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

  本发明涉及新型取代融合氨基哌啶类化合物，其为二肽基肽酶-IV酶（“DPP-IV抑制剂”）的抑制剂，可用于治疗或预防二肽基肽酶-IV酶涉及的疾病，例如糖尿病，特别是2型糖尿病。本发明还涉及包含这些化合物的制药组合物以及在预防或治疗二肽基肽酶-IV酶涉及的这些疾病中使用这些化合物和组合物。
• Fused Aminopiperidine as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
  申请人：Edmondson D. Scott

  公开号：US20080009510A1

  公开（公告）日：2008-01-10

  The present invention is directed to novel substituted fused aminopiperidines which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

  本发明涉及一种新型的取代融合氨基哌啶，它们是二肽基肽酶-IV酶（“DPP-IV抑制剂”）的抑制剂，可用于治疗或预防二肽基肽酶-IV酶参与的疾病，如糖尿病，特别是2型糖尿病。本发明还涉及包含这些化合物的制药组合物以及在预防或治疗二肽基肽酶-IV酶参与的这类疾病中使用这些化合物和组合物的用途。
• WO2007/70434
  申请人：——

  公开号：——

  公开（公告）日：——